Horizons OTC Stock Today

Horizons Betrapro is trading at 15.08 as of the 5th of December 2021, a No Change since the beginning of the trading day. The stock's lowest day price was 15.08. Equity ratings for Horizons Betrapro are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of January 2021 and ending today, the 5th of December 2021. Click here to learn more.

Horizons Betrapro OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Horizons Betrapro's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Horizons Betrapro or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Horizons Betrapro is not yet fully synchronised with the market data
Horizons Betrapro is way too risky over 90 days horizon
Horizons Betrapro appears to be risky and price may revert if volatility continues
Legal NameHorizons Betrapro
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Horizons Betrapro's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
Horizons Betrapro [HZNSF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under '' category with current market capitalization of 0. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Horizons Betrapro's market, we take the total number of its shares issued and multiply it by Horizons Betrapro's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Horizons Betrapro has 7.17 M outstanding shares.
Check Horizons Betrapro Probability Of Bankruptcy

Horizons Stock Price Odds Analysis

What are Horizons Betrapro's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Horizons Betrapro jumping above the current price in 90 days from now is about 47.88%. The Horizons Betrapro probability density function shows the probability of Horizons Betrapro otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Horizons Betrapro has a beta of -0.4866. This usually indicates as returns on benchmark increase, returns on holding Horizons Betrapro are expected to decrease at a much lower rate. During the bear market, however, Horizons Betrapro is likely to outperform the market. Additionally, the company has an alpha of 0.0778, implying that it can generate a 0.0778 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 15.08HorizonTargetOdds Up 15.08 
51.99%90 days
 15.08 
47.88%
Based on a normal probability distribution, the odds of Horizons Betrapro to move above the current price in 90 days from now is about 47.88 (This Horizons Betrapro probability density function shows the probability of Horizons OTC Stock to fall within a particular range of prices over 90 days) .

Horizons Betrapro Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Horizons Betrapro market risk premium is the additional return an investor will receive from holding Horizons Betrapro long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Horizons Betrapro. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Horizons Betrapro's alpha and beta are two of the key measurements used to evaluate Horizons Betrapro's performance over the market, the standard measures of volatility play an important role as well.

Horizons Stock Against Markets

Picking the right benchmark for Horizons Betrapro otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Horizons Betrapro otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Horizons Betrapro is critical whether you are bullish or bearish towards Horizons Betrapro at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Horizons Betrapro otc stock to make a market-neutral strategy. Peer analysis of Horizons Betrapro could also be used in its relative valuation, which is a method of valuing Horizons Betrapro by comparing valuation metrics with similar companies.
Please check Risk vs Return Analysis. Note that the Horizons Betrapro information on this page should be used as a complementary analysis to other Horizons Betrapro's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Horizons OTC Stock analysis

When running Horizons Betrapro price analysis, check to measure Horizons Betrapro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Horizons Betrapro is operating at the current time. Most of Horizons Betrapro's value examination focuses on studying past and present price action to predict the probability of Horizons Betrapro's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Horizons Betrapro's price. Additionally, you may evaluate how the addition of Horizons Betrapro to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Is Horizons Betrapro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Horizons Betrapro. If investors know Horizons will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Horizons Betrapro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Horizons Betrapro is measured differently than its book value, which is the value of Horizons that is recorded on the company's balance sheet. Investors also form their own opinion of Horizons Betrapro's value that differs from its market value or its book value, called intrinsic value, which is Horizons Betrapro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Horizons Betrapro's market value can be influenced by many factors that don't directly affect Horizons Betrapro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Horizons Betrapro's value and its price as these two are different measures arrived at by different means. Investors typically determine Horizons Betrapro value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Horizons Betrapro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.